Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Caspary E. A., Field E. J. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J. 1971 Jun 12;2(5762):613–617. doi: 10.1136/bmj.2.5762.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dumonde D. C., Maini R. N. The clinical significance of mediators of cellular immunity. Clin Allergy. 1971 Mar;1(1):123–139. doi: 10.1111/j.1365-2222.1971.tb02453.x. [DOI] [PubMed] [Google Scholar]
- FIELD E. J., CASPARY E. A., BALL E. J. Some biological properties of a highly active encephalitogenic factor isolated from human brain. Lancet. 1963 Jul 6;2(7297):11–13. doi: 10.1016/s0140-6736(63)92533-9. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A., Carnegie P. R. Lymphocyte sensitization to basic protein of brain in malignant neoplasia: experiments with serotonin and related compounds. Nature. 1971 Sep 24;233(5317):284–286. doi: 10.1038/233284a0. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Is maternal lymphocyte sensitisation passed to the child? Lancet. 1971 Aug 14;2(7720):337–342. doi: 10.1016/s0140-6736(71)90059-6. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
- Field E. J., Caspary E. A. Lymphocyte sensitization in advanced malignant disease: a study of serum lymphocyte depressive factor. Br J Cancer. 1972 Jun;26(3):164–173. doi: 10.1038/bjc.1972.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mathé G., Amiel J. L., Schwarzenberg L., Schneider M., Cattan A., Schlumberger J. R., Hayat M., De Vassal F. Active immunotherapy for acute lymphoblastic leukaemia. Lancet. 1969 Apr 5;1(7597):697–699. doi: 10.1016/s0140-6736(69)92648-8. [DOI] [PubMed] [Google Scholar]